Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression

United States Patent Application Publication
2012
Stephen T. Schultz, Mauris N. DeSilva, & Georgianna G. Gould

The inventive method for the determination of susceptibility or diagnosis of autism or autism spectrum disorders. Diagnosis or determination of susceptibility determinations are predicated on quantitative analysis of endocannibinoid levels or endocannibinoid receptor expres sion.

This library aims to empower you with knowledge but it does not replace the personalized advice and guidance a healthcare professional can provide. Before implementing any changes to your health regimen based on the contents of this library, we strongly advise you to consult with a qualified healthcare professional. Your doctor’s expertise is essential for interpreting how these insights may apply to your unique health circumstances.